Ketorolacdosage

Carefully consider the potential benefits and risks of ketorolac tromethamine tablets and other treatment options before deciding to use ketorolac tromethamine tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. In adults, the combined duration of use of intravenous or intramuscular dosing of ketorolac tromethamine and ketorolac tromethamine tablets is not to exceed 5 days. In adults, the use of ketorolac tromethamine tablets is only indicated as continuation therapy to intravenous or intramuscular dosing of ketorolac tromethamine. Transition from intravenous or intramuscular dosing of ketorolac tromethamine (single- or multiple-dose) to multiple-dose ketorolac tromethamine tablets: Patients age 17 to 64: 20 mg PO once followed by 10 mg q4 hours to 6 hours prn not > 40 mg/day Patients age ≥ 65, renally impaired, and/or weight < 50 kg (110 lbs): 10 mg PO once followed by 10 mg q4 hours to 6 hours prn not > 40 mg/day Note: Oral formulation should not be given as an initial dose Use minimum effective dose for the individual patient Do not shorten dosing interval of 4 hours to 6 hours Total duration of treatment in adult patients: the combined duration of use of intravenous or intramuscular dosing of ketorolac tromethamine and ketorolac tromethamine tablets is not to exceed 5 days. The following table summarizes ketorolac tromethamine tablets dosing instructions in terms of age group: Table 4: Summary of Dosing Instructions Patient Population Ketorolac Tromethamine Tablets (Following Intravenous or Intramuscular dosing of ketorolac tromethamine) Age < 17 years Oral not approved Adult Age 17 years to 64 years 20 mg once, then 10 mg q4 hours to 6 hours prn not > 40 mg/day Adult Age ≥ 65 years, renally impaired, and/or weight < 50 kg 10 mg once, then 10 mg q4 hours to 6 hours prn not > 40 mg/day